Literature DB >> 17113206

Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations.

Sylvain Grignon1, Jean Marc Chianetta.   

Abstract

Oxidative stress has long been suggested to participate in the pathophysiology of schizophrenia. Most of the published data on the subject rely on malondialdehyde levels assessment through thiobarbituric acid reactive substances (TBARS), despite significant methodological concerns. The present paper reports on a meta-analysis of studies published up to July 2006. Relevant studies were identified through PubMed search and the References section of experimental and review papers on the subject. Studies were retained for analysis if they provided adequate methods description, controls and subjects numbers, means and standard deviations. Using a random effect model, an effect size of 1.22 (CI: 0.64-1.80) was found, with significant bias and high heterogeneity. Inspection of the bias assessment plot suggested a lower value in the order of d approximately 0.5, in line with the results of the larger studies. The heterogeneity of the results appeared to be unrelated to assay type or biological sample. However a meta-regression analysis suggested an association, at trend level, between the precision-weighted effect size and the proportion of drug-free patients, which might therefore account for some of the heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113206     DOI: 10.1016/j.pnpbp.2006.09.012

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  17 in total

1.  MK-801 alters Na+, K+-ATPase activity and oxidative status in zebrafish brain: reversal by antipsychotic drugs.

Authors:  Kelly Juliana Seibt; Renata da Luz Oliveira; Denis Broock Rosemberg; Luiz Eduardo Baggio Savio; Emilene B S Scherer; Felipe Schmitz; Angela T S Wyse; Carla Denise Bonan
Journal:  J Neural Transm (Vienna)       Date:  2011-12-06       Impact factor: 3.575

2.  Impaired metabolic reactivity to oxidative stress in early psychosis patients.

Authors:  Margot Fournier; Carina Ferrari; Philipp S Baumann; Andrea Polari; Aline Monin; Tanja Bellier-Teichmann; Jacob Wulff; Kirk L Pappan; Michel Cuenod; Philippe Conus; Kim Q Do
Journal:  Schizophr Bull       Date:  2014-03-31       Impact factor: 9.306

3.  Meta-analysis of oxidative stress in schizophrenia.

Authors:  Joshua Flatow; Peter Buckley; Brian J Miller
Journal:  Biol Psychiatry       Date:  2013-05-15       Impact factor: 13.382

4.  Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.

Authors:  Zhi-Le Bai; Xue-Song Li; Guang-Yang Chen; Yang Du; Ze-Xu Wei; Xi Chen; Guang-En Zheng; Wen Deng; Yong Cheng
Journal:  J Mol Neurosci       Date:  2018-10-09       Impact factor: 3.444

5.  Oxidative stress in schizophrenia.

Authors:  Marija Bošković; Tomaž Vovk; Blanka Kores Plesničar; Iztok Grabnar
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

Review 6.  Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?

Authors:  Jana Trebatická; Zdeňka Ďuračková
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

7.  Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.

Authors:  Anna Dietrich-Muszalska; Justyna Kopka; Bogdan Kontek
Journal:  Schizophr Res Treatment       Date:  2014-06-25

8.  Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model.

Authors:  Sema Inanir; Umit Sertan Copoglu; Hanifi Kokacya; Recep Dokuyucu; Oytun Erbas; Ahmet Inanir
Journal:  Med Sci Monit       Date:  2015-12-08

9.  Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia.

Authors:  Burak Kulaksizoglu; Sibel Kulaksizoglu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-12       Impact factor: 2.570

10.  Impaired fornix-hippocampus integrity is linked to peripheral glutathione peroxidase in early psychosis.

Authors:  P S Baumann; A Griffa; M Fournier; P Golay; C Ferrari; L Alameda; M Cuenod; J-P Thiran; P Hagmann; K Q Do; P Conus
Journal:  Transl Psychiatry       Date:  2016-07-26       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.